Exelixis, Inc. (EXEL)
42.68
-0.26
(-0.61%)
USD |
NASDAQ |
Feb 12, 16:00
42.70
+0.02
(+0.05%)
After-Hours: 20:00
Exelixis Total Liabilities (Quarterly) : 720.71M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Natera, Inc. | 569.29M |
| Merck & Co., Inc. | -- |
| Gilead Sciences, Inc. | 36.40B |
| ADMA Biologics, Inc. | 137.50M |
| Axsome Therapeutics, Inc. | 595.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.882B |
| Shareholders Equity (Quarterly) | 2.161B |
| Debt to Equity Ratio | 0.093 |
| Current Ratio | 3.558 |
| Net Debt Paydown Yield | -0.01% |